CALA (CALA) Stock Price & Analysis
CALA (CALA) rose 0.00% to USD 0 as of September 8, 2026 at 08:17 UTC, according to Nexqual real-time market data.
CALA last closed at USD 0; the session ranged USD 0–0 on volume of 315 shares. Market capitalization is —, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, September 8, 2026 at 08:17 UTC.
Key Statistics (as of September 8, 2026 at 08:17 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 315 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (CALA)
Nexqual's technical model rates CALA "BUY" based on 5 bullish and 2 bearish signals across 129 daily candles, as of September 8, 2026 at 08:17 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 70.87 (overbought) |
| vs SMA50 | Above (USD 0) |
| MACD | 0 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SYRS | Syros Pharmaceuticals, Inc. | USD 0 | ▲ 0% |
| AFMDQ | Affimed N.V. | USD 0 | ▲ 0% |
| CBIO | Crescent Biopharma, Inc. | USD 20.88 | ▲ 12.62% |
| AKBA | Akebia Therapeutics, Inc. | USD 0.97 | ▼ 0.54% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:17 UTC. This page is informational and not investment advice.